Press releases

  • 19. 11. 2015

    Krka presented its operating results for the first nine months of 2015

    Novo mesto, 19 November 2015 – The Management Board of Krka, d. d. held a press conference today presenting to the public the performance results of the Krka Group and the Krka Company for the first nine months of 2015, which the Krka Supervisory Board had discussed at its yesterday's meeting. The Krka Group sold EUR 863.3 million worth of products and generated EUR 133.3 million of profit for the period (up 5%). The Krka Company sold EUR 827 million worth of products and generated EUR 134.9 million of profit for the period (up 12%).

  • 5. 11. 2015

    Krka opens Notol 2 plant – our largest investment to date

    Ločna, 4 November 2015 – Notol 2, solid dosage forms production plant, has been officially opened today at Krka's main location with the Slovenian Prime Minister Dr Miro Cerar attending the ceremony. The investment is worth EUR 200 million and provides Krka new capacities for applying the vertically integrated business model, allowing it to control the entire process from development to production of raw materials and finished products. The new plant will facilitate the production of 4.5 billion tablets and capsules per year; production started earlier this year in February. Its advantage is a high level of automation and computer support with an emphasis on a computer-controlled production system and an automated computer-controlled system of material flow. The conceptual design of the plant is the result of knowledge and teamwork of Krka's experts.

  • 7. 10. 2015

    Krka opens a new plant for the production of active pharmaceutical ingredients in Krško

    Krško, 6 October 2015 - Krka has opened today a new plant for the production of active pharmaceutical ingredients (APIs), Sinteza 1, in Krško, Slovenia. The investment is worth EUR 85 million and gives Krka new capacities for maintaining the entire process from development to production of raw materials and finished products. The new plant will produce APIs for vertically integrated medicines, which represent more than 70% of Krka's product portfolio.

  • 26. 8. 2015

    Krka presented its operating results for the first half of 2015

    Novo mesto, 26 August 2015 – The Management Board of Krka, d. d. held a press conference today presenting to the public the performance results of the Krka Group and the Krka Company for the first half of 2015, which the Krka Supervisory Board had discussed at its yesterday's meeting. The Krka Group sold EUR 599.9 million worth of products and generated EUR 112.3 million of net profit (up 5%) in the six months to June. The Krka Company sold EUR 569.9 million worth of products and generated EUR 108.5 million of net profit (up 10%).

  • 20. 8. 2015

    21st Krka Annual General Meeting

    Otočec, 20 August 2015 – Krka, d. d., Novo mesto held its 21st Annual General Meeting today in Hotel Šport in Otočec, Slovenia. The present shareholders represented 58.39% of share capital with voting rights. In addition to other business, the AGM deliberated on the appropriation of accumulated profit for 2014 and decided to pay shareholders a gross dividend of EUR 2.50 per share, representing a 19% increase over the last year dividend.